C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
11/2002
11/12/2002	US6479524 To prolong the thrombin time
11/12/2002	US6479508 Viral polymerase inhibitors
11/12/2002	US6479425 Can be used to produce polymers and copolymers containing polar monomers
11/12/2002	CA2103242C Imidazo[2,1-b][3]benzazepine derivatives, compositions and method of use
11/07/2002	WO2002088274A1 Double-spiro organic compounds and electroluminescent devices
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088093A1 Benzimidazoles that are useful in treating sexual dysfunction
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088073A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002	DE10214515A1 New curable compound is liquid state before curing and soften/liquefy in short time after curing at lower temperature than thermal decomposition point
11/07/2002	CA2439943A1 Benzimidazoles that are useful in treating sexual dysfunction
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1064275B1 Process for producing simvastatin and/or its derivatives
11/06/2002	EP0906288B1 New compounds
11/06/2002	CN1378540A New piperazine and piperidine compounds
11/06/2002	CN1377868A Method for reducing N oxo-compound
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002	US6476045 Indole and azaindole derivatives and their use as tachykinin antagonists, and in particular as neurokinin-1 receptor antagonist
11/05/2002	US6476040 Processes and intermediates for preparing anti-cancer compounds
11/05/2002	CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002085866A1 Novel compounds
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002085357A1 Nociceptin analogs
10/31/2002	WO2001056563A9 Adamantyl derivatives as anti-cancer agents
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161234 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde
10/31/2002	CA2444381A1 Novel compounds
10/30/2002	EP0998462B1 Process for the preparation of 1,3-diaza-spiro (4.4) non-1-en-4-one derivatives and 1-cyano-1-acylamino-cyclopentane intermediates
10/30/2002	CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/29/2002	CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/24/2002	WO2002083649A1 Novel imidazolidinedione derivatives and use thereof as drugs
10/24/2002	WO2002083608A2 Methods of preparing sulfinamide and sulfoxides
10/24/2002	WO2002083143A1 Cxcr3 antagonists
10/24/2002	US20020156299 Novel carboxylic acid derivatives and process for producing the same
10/24/2002	US20020156284 Crystalline form of omeprazole
10/24/2002	US20020156111 Substituted bicyclic compounds
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/23/2002	EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002	CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469039 Benzimidazoles; thrombin- inhibiting activity and the effect of extending thrombin time
10/22/2002	US6469004 Benzoheterocycles and their uses as MEK inhibitors
10/22/2002	CA2227264C Amine acid salt compounds and process for the production thereof
10/17/2002	WO2002081463A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002	WO2002081443A1 Novel guanidino compounds
10/17/2002	WO2002044156A3 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
10/17/2002	US20020151723 Such as 1-(cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-((2'-(1H-tetrazol-t-yl)biphenyl-4-yl)methyl)benzimidazol-7-carboxylate; exhibits antihypertensive activity and strong angiotensin II antagonistic activity
10/17/2002	US20020151720 Naphthol derivatives
10/17/2002	US20020151575 Heterocyclic topoisomerase poisons
10/17/2002	US20020151531 Administering to a female of child bearing age over a period of 28 consecutive days a first phase of from 18 to 21 daily dosage units of a progestational agent, and a second phase of from 1 to 7 daily dosage units of an antiprogestin agent
10/17/2002	CA2442776A1 Antagonists of mcp-1 function and methods of use thereof
10/16/2002	EP1248615A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
10/16/2002	EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/16/2002	EP0538297B9 Antiviral tetrahydroimidazo 1,4]benzodiazepin-2-(thio)ones
10/16/2002	CN1374952A Benzimidazolone derivatives and their use as phosphodiesterase inhibibors
10/16/2002	CN1374865A Nociceptin receptor ORL-1 agonists for use in treating cough
10/15/2002	US6465658 Reacting azolide salts with phosgene in an aromatic compound or an ether as solvent
10/15/2002	US6465505 Benzyl-substituted benzimidazoles
10/15/2002	US6465484 Tyrosine kinase inhibitors; cancer, atherosclerosis, diabetic retinopathy, autoimmune diseases, inflammatory diseases
10/15/2002	US6465478 Analgesics, antiinflammatories, diuretics, anesthetics, neuroprotective agents, antihypertensive or antianxiety agent, appetite control, hearing regulation
10/15/2002	CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/10/2002	WO2002057215A3 Sodium channel modulators
10/09/2002	WO2001079168A1 Nitrogenous compounds and antiviral drugs containing the same
10/09/2002	EP1246808A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
10/09/2002	EP1246795A2 Antibacterial agents
10/09/2002	CN1373757A Heterocyclically substd, benzoylguanidine, method for production thereof, use thereof as medicament or means of diagnosis and medicaments contg. same
10/09/2002	CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
10/09/2002	CA2405690A1 Nitrogen-containing compounds and antiviral drugs containing the same
10/08/2002	US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
10/08/2002	US6462064 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
10/08/2002	US6462062 Compounds and methods for use thereof in the treatment of cancer or viral infections
10/08/2002	US6462060 Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/08/2002	CA2196769C Benzimidazole derivatives having dopaminergic activity
10/03/2002	WO2002077145A1 Composition and method for bleachin g a substrate
10/03/2002	WO2002076963A1 Bicyclic guanidine derivatives and therapeutic uses thereof
10/03/2002	WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002	WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002	WO2002076454A1 Method for treatment of cancer and compositions for use therein
10/03/2002	WO2002062766A3 Melanocortin-4 receptor binding compounds and methods of use thereof
10/03/2002	US20020142921 Oil-soluble additives for lubricating oils
10/03/2002	CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002	CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002	EP1244639A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
10/02/2002	EP1244636A1 Benzimidazoles, production thereof and the use thereof as antithrombotic
10/02/2002	EP1244446A1 Thrombopoietin mimetics
10/02/2002	EP0841924B1 Benzimidazole compounds
10/02/2002	CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/01/2002	US6458785 Aids therapy
10/01/2002	US6458784 Vitronectin receptor antagonists
09/2002
09/26/2002	WO2002074752A1 Metalloproteinase inhibitors
09/26/2002	WO2002074750A1 Metalloproteinase inhibitors
09/26/2002	WO2002074749A1 Metalloproteinase inhibitors
09/26/2002	WO2002062796A8 Epindolidione pigments
09/26/2002	WO2002062780A3 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
09/26/2002	WO2002024636A3 N-acylsulfonamide apoptosis promoters

1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 154